National Health (Growth Hormone program) Special Arrangement Amendment Instrument 2015 (No. 1) (PB 96 of 2015) (Cth)
PB 96 of 2015
National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2015 (No. 1)
National Health Act 1953
I, JULIANNE QUAINE, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Amendment Instrument under subsections 100(1) and 100(2) of the National Health Act 1953.
Dated 26 November 2015
Julianne Quaine
Assistant Secretary
Pharmaceutical Access Branch
Pharmaceutical Benefits Division
Department of Health
_____________________________________________________________________
1 Name of Instrument
(1) This Instrument is the National Health (Growth Hormone Program) Special Arrangement Amendment Instrument 2015 (No.1).
(2) This Instrument may also be cited as PB 96 of 2015.
2 Commencement
(1) This instrument commences on 1 December 2015.
3 Amendment of PB 85 of 2015
Schedule 1 amends the National Health (Growth Hormone Program) Special Arrangement 2015 (PB 85 of 2015).
Schedule 1 Amendments
[1] Schedule 1, after the entry for the listed drug Somatropin, in the form Solution for injection 5 mg (15 i.u.) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection, and Brand Omintrope
insert:
Omnitrope Surepal 5
D(100)
[2] Schedule 1, after the entry for the listed drug Somatropin, in the form Solution for injection 10 mg (30 i.u.) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection, and Brand Omnitrope
insert:
Omnitrope Surepal 10
D(100)
[3] Schedule 1, entry for the listed drug Somatropin, in the form Solution for injection 15 mg (45 i.u) in 1.5 mL cartridge (with preservative), with the manner of administration of Injection
a) omit from the column headed ‘Brand’: Omnitrope SurePal
b) insert in the column headed ‘Brand’: Omnitrope Surepal 15
0
0
0